NPRRF Nipro Corporation (PNK) at $8.23 on 13 Feb 2026: Oversold bounce setup to monitor

NPRRF stock opened regular trading on 13 Feb 2026 at $8.50 and sits at $8.23 as of this market hours update. The setup looks like a short-term oversold bounce candidate given thin liquidity and a recent volume uptick (volume 1,150.00, avg 543.00). Key fundamentals include EPS 0.19 and PE 43.32, which paint a mixed growth and valuation picture for this healthcare name listed on PNK in the United States. We show technical triggers, Meyka AI grading, and practical trade ideas for an oversold bounce approach.

Market snapshot and price action for NPRRF stock

Nipro Corporation (NPRRF) trades on PNK in the United States at $8.23 with a day range of $8.23–$8.50. Market cap is 1,342,276,352.00 USD and shares outstanding are 163,095,547.00. The stock printed year high $8.50 and year low $8.23, showing a narrow trading band and thin liquidity. One clear fact: relative volume is 2.12, so today’s activity exceeds typical volume, which can trigger an oversold bounce in low-float names.

Technical setup: NPRRF stock oversold bounce

Price action shows a compressed range with limited indicator signals and a recent volume spike. Short-term traders can watch a pullback entry near $8.10 and a first target at intraday resistance $8.50. Risk control is essential because average volume is low and the float is concentrated.

Fundamentals and earnings context for Nipro Corporation

Nipro’s FY revenue grew 9.85% while net income fell 53.97% year over year, per the latest fiscal data. EPS stands at 0.19 USD, producing a PE of 43.32. Operating income improved 19.09%, and free cash flow rose 61.80%, which helps offset profit volatility. The company serves medical devices, pharma and packaging markets, which gives it diversified healthcare exposure.

Meyka AI grade and forecast for NPRRF

Meyka AI rates NPRRF with a score out of 100. Meyka AI rates NPRRF with a score of 67.66 out of 100 — Grade B — Suggestion: HOLD. This grade factors in S&P 500 comparison, sector and industry performance, financial growth, key metrics, forecasts, and analyst consensus. Meyka AI’s forecast model projects a monthly price of 8.59 USD (implied upside 4.37% vs current 8.23 USD) and a yearly projection of 7.96 USD (implied downside -3.29%). Forecasts are model-based projections and not guarantees.

Price targets, trade plan and valuation checkpoints

For an oversold bounce play consider a short-term target range: conservative $7.50, base $8.50, and bullish $9.50. Position size should be small because PE is 43.32 and earnings showed a net income decline. Watch support near $8.10 and stop below $7.80 for disciplined risk management. Check sector performance in Healthcare to confirm strength before adding exposure.

Risks and catalysts for NPRRF trading

Key risks include thin liquidity, concentrated share ownership, and earnings volatility. Catalysts that could fuel a bounce are stronger pharma packaging orders, positive product contract wins, or better-than-expected quarterly margins. Monitor headlines on the company website and employee sentiment on public profiles for incremental signals source and workforce trends source.

Final Thoughts

Quick take: NPRRF stock shows a textbook oversold bounce candidate in regular market hours on 13 Feb 2026. The price sits at 8.23 USD after opening at 8.50 USD, with volume 1,150.00 and relative volume 2.12, which signals increased trader attention. Fundamentals are mixed: revenue growth 9.85% but net income down 53.97%, EPS 0.19 USD, and PE 43.32. Meyka AI’s forecast model projects a monthly level of 8.59 USD, suggesting an implied near-term upside of 4.37% versus current price. Our Meyka AI grade is 67.66/100 (B, HOLD), reflecting balanced sector exposure but clear execution risk. For traders targeting an oversold bounce, use tight risk controls, a stop near 7.80 USD, and scale out at the 8.50–9.50 USD zone. Remember, forecasts and grades are model-based and not guarantees. Meyka AI provides this as an AI-powered market analysis platform insight to help shape your research and trade plan.

FAQs

Disclaimer:

Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.